This is the authors' abstract. We don't add key points for this paper.
The control of genotoxic impurities (GTIs) is a crucial activity that is performed for any new chemical entity intended for clinical use. A key element of this is the quality risk assessment. This article seeks to examine the primary components of such a strategy, focusing specifically on the effective use of in silico assessment tools to augment this process, in particular the calculation of theoretical purge factors based on the physicochemical properties of a specific GTI and its interrelationship to the process.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Teasdale et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: